New weight loss pill MWN109 enters first human safety trial
Symptom relief
Recruiting now
This early-stage study tests a new tablet called MWN109 in healthy adults who are overweight or have obesity. The main goal is to check if the drug is safe and how the body processes it. About 60 participants will receive either the drug or a placebo, and researchers will monitor…
Phase: PHASE1 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC